How much cash does Dogwood Therapeutics generate?

Dogwood Therapeutics (DWTX) generated -$15.5M in operating cash flow over the trailing twelve months.

Where does Dogwood Therapeutics's cash flow data come from?

Every line is extracted from Dogwood Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Dogwood Therapeutics DWTX Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Net income	-$34.26M-177%	-$12.35M-133%	-$5.3M+56.8%	-$12.25M+23.3%
Depreciation and amortization	——	$12.18K—	——	——
Stock-based compensation	$355.64K-25.3%	$476.02K-23.2%	$619.97K+6.4%	$582.66K+80.5%
Net cash from operating activities	-$15.62M-77.7%	-$8.79M-80.5%	-$4.87M+57.5%	-$11.47M+26.9%
Acquisitions, net of cash acquired	——	$3.76M—	——	——
Net cash from investing activities	——	$3.76M—	——	——
Net cash from financing activities	——	——	$1.16M-74.2%	$4.49M—
Net increase (decrease) in cash	-$8.33M-171%	$11.68M+399%	-$3.91M—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Dogwood Therapeutics generate?: Dogwood Therapeutics (DWTX) generated -$15.5M in operating cash flow over the trailing twelve months.
Where does Dogwood Therapeutics's cash flow data come from?: Every line is extracted from Dogwood Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.